Siddavaram Nagini

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Cell Cycle Arrest

Tyrosine Kinase

Anti Inflammatory

Top Venues

Current pharmaceutical biotechnology

Medicinal research reviews

Phytotherapy research : PTR

This page only lists publications with an associated author ORCID identifier.

Publications

Soundararajan Arvindh, Manashi Priyadarshini, Abdul Basit Baba, Veeran Veeravarmal, Rajakishore Mishra, Rupesh Dash, Siddavaram Nagini
The Neem Limonoid Nimbolide Modulates Key Components of the DNA Damage Response Signalling in Cellular and Animal Models of Oral Squamous Cell Carcinoma. Current pharmaceutical biotechnology (2024)
Soundararajan Arvindh, Manashi Priyadarshini, Abdul Basit Baba, Veeran Veeravarmal, Rajakishore Mishra, Rupesh Dash, Siddavaram Nagini
The Neem Limonoid Nimbolide Modulates Key Components of the DNA Damage Response Signalling in Cellular and Animal Models of Oral Squamous Cell Carcinoma Current pharmaceutical biotechnology (2024)
Anupam Bishyaee, Amanda Penn, Neha Bhandari, Riley Petrovich, Lindsay K DeLiberto, Jack T Burcher, Sandra Maria Barbalho, Siddavaram Nagini
Dietary plants for oral cancer prevention and therapy: A review of preclinical and clinical studies. Phytotherapy research : PTR (2024)
Siddavaram Nagini, Manikandan Palrasu, Anupam Bishyaee
Limonoids from neem (Azadirachta Indica A. Juss.) are potential anticancer drug candidates. Medicinal research reviews (2023)
Siddavaram Nagini, Ramesh Nivetha, Manikandan Palrasu, Rajakishore Mishra
Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal. Journal of medicinal chemistry 64 (7) (2021)
Jaganathan Kowshik, Ramesh Nivetha, Singaraj Ranjani, Palanivel Venkatesan, Subramanian Selvamuthukumar, Veeran Veeravarmal, Siddavaram Nagini
Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF-κΒ/STAT3 signalling axis in oral squamous cell carcinoma models. IUBMB life 71 (10) (2019)